Cargando…
Serum protein signature of coronary artery disease in type 2 diabetes mellitus
BACKGROUND: Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). The purpose of the present study was to discriminate the Indian CAD patients with or without T2DM by using multiple pathophysiological biomarkers. METHODS: Usin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345069/ https://www.ncbi.nlm.nih.gov/pubmed/30674322 http://dx.doi.org/10.1186/s12967-018-1755-5 |
_version_ | 1783389522012143616 |
---|---|
author | Adela, Ramu Reddy, Podduturu Naveen Chander Ghosh, Tarini Shankar Aggarwal, Suruchi Yadav, Amit Kumar Das, Bhabatosh Banerjee, Sanjay K. |
author_facet | Adela, Ramu Reddy, Podduturu Naveen Chander Ghosh, Tarini Shankar Aggarwal, Suruchi Yadav, Amit Kumar Das, Bhabatosh Banerjee, Sanjay K. |
author_sort | Adela, Ramu |
collection | PubMed |
description | BACKGROUND: Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). The purpose of the present study was to discriminate the Indian CAD patients with or without T2DM by using multiple pathophysiological biomarkers. METHODS: Using sensitive multiplex protein assays, we assessed 46 protein markers including cytokines/chemokines, metabolic hormones, adipokines and apolipoproteins for evaluating different pathophysiological conditions of control, T2DM, CAD and T2DM with CAD patients (T2DM_CAD). Network analysis was performed to create protein-protein interaction networks by using significantly (p < 0.05) altered protein markers in each disease using STRING 10.5 database. We used two supervised analysis methods i.e., between class analysis (BCA) and principal component analysis (PCA) to reveals distinct biomarkers profiles. Further, random forest classification (RF) was used to classify the diseases by the panel of markers. RESULTS: Our two supervised analysis methods BCA and PCA revealed a distinct biomarker profiles and high degree of variability in the marker profiles for T2DM_CAD and CAD. Thereafter, the present study identified multiple potential biomarkers to differentiate T2DM, CAD, and T2DM_CAD patients based on their relative abundance in serum. RF classified T2DM based on the abundance patterns of nine markers i.e., IL-1β, GM-CSF, glucagon, PAI-I, rantes, IP-10, resistin, GIP and Apo-B; CAD by 14 markers i.e., resistin, PDGF-BB, PAI-1, lipocalin-2, leptin, IL-13, eotaxin, GM-CSF, Apo-E, ghrelin, adipsin, GIP, Apo-CII and IP-10; and T2DM _CAD by 12 markers i.e., insulin, resistin, PAI-1, adiponectin, lipocalin-2, GM-CSF, adipsin, leptin, Apo-AII, rantes, IL-6 and ghrelin with respect to the control subjects. Using network analysis, we have identified several cellular network proteins like PTPN1, AKT1, INSR, LEPR, IRS1, IRS2, IL1R2, IL6R, PCSK9 and MYD88, which are responsible for regulating inflammation, insulin resistance, and atherosclerosis. CONCLUSION: We have identified three distinct sets of serum markers for diabetes, CAD and diabetes associated with CAD in Indian patients using nonparametric-based machine learning approach. These multiple marker classifiers may be useful for monitoring progression from a healthy person to T2DM and T2DM to T2DM_CAD. However, these findings need to be further confirmed in the future studies with large number of samples. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1755-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6345069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63450692019-01-29 Serum protein signature of coronary artery disease in type 2 diabetes mellitus Adela, Ramu Reddy, Podduturu Naveen Chander Ghosh, Tarini Shankar Aggarwal, Suruchi Yadav, Amit Kumar Das, Bhabatosh Banerjee, Sanjay K. J Transl Med Research BACKGROUND: Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). The purpose of the present study was to discriminate the Indian CAD patients with or without T2DM by using multiple pathophysiological biomarkers. METHODS: Using sensitive multiplex protein assays, we assessed 46 protein markers including cytokines/chemokines, metabolic hormones, adipokines and apolipoproteins for evaluating different pathophysiological conditions of control, T2DM, CAD and T2DM with CAD patients (T2DM_CAD). Network analysis was performed to create protein-protein interaction networks by using significantly (p < 0.05) altered protein markers in each disease using STRING 10.5 database. We used two supervised analysis methods i.e., between class analysis (BCA) and principal component analysis (PCA) to reveals distinct biomarkers profiles. Further, random forest classification (RF) was used to classify the diseases by the panel of markers. RESULTS: Our two supervised analysis methods BCA and PCA revealed a distinct biomarker profiles and high degree of variability in the marker profiles for T2DM_CAD and CAD. Thereafter, the present study identified multiple potential biomarkers to differentiate T2DM, CAD, and T2DM_CAD patients based on their relative abundance in serum. RF classified T2DM based on the abundance patterns of nine markers i.e., IL-1β, GM-CSF, glucagon, PAI-I, rantes, IP-10, resistin, GIP and Apo-B; CAD by 14 markers i.e., resistin, PDGF-BB, PAI-1, lipocalin-2, leptin, IL-13, eotaxin, GM-CSF, Apo-E, ghrelin, adipsin, GIP, Apo-CII and IP-10; and T2DM _CAD by 12 markers i.e., insulin, resistin, PAI-1, adiponectin, lipocalin-2, GM-CSF, adipsin, leptin, Apo-AII, rantes, IL-6 and ghrelin with respect to the control subjects. Using network analysis, we have identified several cellular network proteins like PTPN1, AKT1, INSR, LEPR, IRS1, IRS2, IL1R2, IL6R, PCSK9 and MYD88, which are responsible for regulating inflammation, insulin resistance, and atherosclerosis. CONCLUSION: We have identified three distinct sets of serum markers for diabetes, CAD and diabetes associated with CAD in Indian patients using nonparametric-based machine learning approach. These multiple marker classifiers may be useful for monitoring progression from a healthy person to T2DM and T2DM to T2DM_CAD. However, these findings need to be further confirmed in the future studies with large number of samples. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1755-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-24 /pmc/articles/PMC6345069/ /pubmed/30674322 http://dx.doi.org/10.1186/s12967-018-1755-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Adela, Ramu Reddy, Podduturu Naveen Chander Ghosh, Tarini Shankar Aggarwal, Suruchi Yadav, Amit Kumar Das, Bhabatosh Banerjee, Sanjay K. Serum protein signature of coronary artery disease in type 2 diabetes mellitus |
title | Serum protein signature of coronary artery disease in type 2 diabetes mellitus |
title_full | Serum protein signature of coronary artery disease in type 2 diabetes mellitus |
title_fullStr | Serum protein signature of coronary artery disease in type 2 diabetes mellitus |
title_full_unstemmed | Serum protein signature of coronary artery disease in type 2 diabetes mellitus |
title_short | Serum protein signature of coronary artery disease in type 2 diabetes mellitus |
title_sort | serum protein signature of coronary artery disease in type 2 diabetes mellitus |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345069/ https://www.ncbi.nlm.nih.gov/pubmed/30674322 http://dx.doi.org/10.1186/s12967-018-1755-5 |
work_keys_str_mv | AT adelaramu serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus AT reddypodduturunaveenchander serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus AT ghoshtarinishankar serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus AT aggarwalsuruchi serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus AT yadavamitkumar serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus AT dasbhabatosh serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus AT banerjeesanjayk serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus |